Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 174636-32-9 Chemical Structure| 174636-32-9

Structure of Talnetant
CAS No.: 174636-32-9

Chemical Structure| 174636-32-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Talnetant is a potent and selective NK3 receptor antagonist (ki=1.4 nM, hNK-3-CHO), and is 100-fold selective for the hNK-3 versus hNK-2 receptor, with no affinity for the hNK-1 at concentrations up to 100 μM.

Synonyms: SB 223412

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Talnetant

CAS No. :174636-32-9
Formula : C25H22N2O2
M.W : 382.45
SMILES Code : O=C(C1=C(O)C(C2=CC=CC=C2)=NC3=CC=CC=C13)N[C@H](C4=CC=CC=C4)CC
Synonyms :
SB 223412
MDL No. :MFCD00944075
InChI Key :BIAVGWDGIJKWRM-FQEVSTJZSA-N
Pubchem ID :5311424

Safety of Talnetant

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P264-P270-P301+P310+P330-P405-P501
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00049946 Schizophrenia Phase 2 Completed - -
NCT00300963 Schizophrenia Phase 2 Completed - United States, Arkansas ... More >> GSK Investigational Site Little Rock, Arkansas, United States, 72201 United States, California GSK Investigational Site Anaheim, California, United States, 92805 GSK Investigational Site Cerritos, California, United States, 90703 GSK Investigational Site Garden Grove, California, United States, 92845 GSK Investigational Site Glendale, California, United States, 91206 GSK Investigational Site National City, California, United States, 91950 GSK Investigational Site Oceanside, California, United States, 92056 GSK Investigational Site Pico Rivera, California, United States, 90660 GSK Investigational Site Rosemead, California, United States, 91770 GSK Investigational Site San Diego, California, United States, 92123 GSK Investigational Site Upland, California, United States, 91786 United States, District of Columbia GSK Investigational Site Washington, District of Columbia, United States, 20016 United States, Florida GSK Investigational Site North Miami, Florida, United States, 33161 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30308 United States, Missouri GSK Investigational Site St. Louis, Missouri, United States, 63118 United States, New Jersey GSK Investigational Site Clementon, New Jersey, United States, 08021 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19131 United States, Texas GSK Investigational Site Austin, Texas, United States, 78756 GSK Investigational Site Irving, Texas, United States, 75062 United States, Virginia GSK Investigational Site Richmond, Virginia, United States, 23294 Less <<
NCT00103727 Schizophrenia Phase 2 Completed - United States, Arkansas ... More >> GSK Investigational Site Little Rock, Arkansas, United States, 72201 United States, California GSK Investigational Site Anaheim, California, United States, 92805 GSK Investigational Site Cerritos, California, United States, 90703 GSK Investigational Site Garden Grove, California, United States, 92845 GSK Investigational Site Glendale, California, United States, 91206 GSK Investigational Site National City, California, United States, 91950 GSK Investigational Site Oceanside, California, United States, 92056 GSK Investigational Site Pico Rivera, California, United States, 90660 GSK Investigational Site Rosemead, California, United States, 91770 GSK Investigational Site San Diego, California, United States, 92123 GSK Investigational Site San Diego, California, United States, 92126 GSK Investigational Site Upland, California, United States, 91786 United States, District of Columbia GSK Investigational Site Washington, District of Columbia, United States, 20016 United States, Florida GSK Investigational Site North Miami, Florida, United States, 33161 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30308 United States, Illinois GSK Investigational Site Oak Brook, Illinois, United States, 60523 United States, Missouri GSK Investigational Site St. Louis, Missouri, United States, 63118 United States, New Jersey GSK Investigational Site Clementon, New Jersey, United States, 08021 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19131 United States, Texas GSK Investigational Site Austin, Texas, United States, 78756 GSK Investigational Site Irving, Texas, United States, 75062 United States, Virginia GSK Investigational Site Richmond, Virginia, United States, 23294 Less <<
NCT00101985 Irritable Colon Phase 2 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.61mL

0.52mL

0.26mL

13.07mL

2.61mL

1.31mL

26.15mL

5.23mL

2.61mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories